Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

Freemantle, N., Lafuente-Lafuente, C., Mitchell, S., Eckert, L., Reynolds, M.·2011·Europace
DOI 10.1093/europace/euq450

Cited by (244)

Items 101–200 of 244

  1. The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST
    Elena Arbelo, Nikolaos Dagres · 2022 · EP Europace
  2. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation
    Wei‐Ru Chiou, Chun‐Che Huang, Po‐Lin Lin, Jen-Yu Chuang, Lawrence Yu‐Min Liu, Min‐I Su, Feng‐Ching Liao, Chun‐Yen Chen, Jen‐Yuan Kuo, Cheng‐Ting Tsai et al. · 2020 · American Journal of Cardiovascular Drugs
  3. Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation
    Serkan Çay, Meryem Kara, Fırat Özcan, Özcan Özeke, Tolga Aksu, Dursun Aras, Serkan Topaloğlu · 2022 · Journal of Interventional Cardiac Electrophysiology
  4. Atrial fibrillation and the pharmacological treatment: the role of propafenone.
    Alfonso Sestito, E. Molina · 2012 · PubMed
  5. Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells
    Adéla Krajčová, Vlasta Němcová‐Fürstová, Milada Halačová, Petr Waldauf, Martin Balík, František Duška · 2023 · Toxicology and Applied Pharmacology
  6. Antiarrhythmic properties of ranolazine – from bench to bedside
    Stylianos E. Tzeis, George K. Andrikopoulos · 2012 · Expert Opinion on Investigational Drugs
  7. Comparison of Amiodarone and Propafenone in Blanking Period after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation: A Propensity Score‐Matched Study
    Rong-Da Huang, Jingjing Lin, Ke-Zeng Gong, Lianglong Chen, Lin Fan, Feilong Zhang, Yan Zhang, XueHai Chen, Zhe Xu · 2020 · BioMed Research International
  8. Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
    Nikolay Yu. Mironov, Yu. A. Yuricheva, Vladislav V. Vlodzyanovsky, Sergei F. Sokolov, Дзаурова Хава Муссаевна, Golitsyn Sp, Yu. V. Shubik, M. V. Berman, М. М. Медведев, А. Е. Ривин et al. · 2021 · Rational Pharmacotherapy in Cardiology
  9. Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter
    Avinash Khitri, Etienne Aliot, Alessandro Capucci, Stuart J. Connolly, Harry J.G.M. Crijns, Stefan Hans Hohnloser, Piotr Kułakowski, Denis Roy, David Radzik, Peter R. Kowey · 2011 · Journal of Cardiovascular Electrophysiology
  10. Catheter ablation of atrial fibrillation in elderly and very elderly patients: safety, outcomes, and quality of life
    Chadi Tabaja, Arwa Younis, Pasquale Santangeli, Ruth A. Madden, Tyler Louis Taigen, Medhat Farwati, Katsuhide Hayashi, Lorenzo Braghieri, John Rickard, Benjamin M. Klein et al. · 2023 · Journal of Interventional Cardiac Electrophysiology
  11. Comparison of Safety of Sotalol Versus Amiodarone in Patients With Atrial Fibrillation and Coronary Artery Disease
    Jonathan Paul Piccini, Sana M. Al‐Khatib, DANIEL M. WOJDYLA, Linda K. Shaw, John R. Horton, Yuliya V. Lokhnygina, Kevin Joseph Anstrom, Tracy A. DeWald, Nancy M. Allen LaPointe, Benjamin Adam Steinberg et al. · 2014 · The American Journal of Cardiology
  12. Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation
    Earl L. Goehring, Rhonda L. Bohn, John C. Pezzullo, Arlene K. Tave, Judith K. Jones, Sylvie Bozzi, Ret. CAPT Sally G. Tamayo, Nicholas Sicignano, Gerald V. Naccarelli · 2020 · The American Journal of Cardiology
  13. Antiarrhythmic Drug Therapy for Atrial Fibrillation
    Muhammad Rizwan Sardar, Wajeeha Saeed, Peter Russell Kowey · 2014 · Cardiology Clinics
  14. Biological Therapies for Atrial Fibrillation
    J. Kevin Donahue · 2015 · Journal of Cardiovascular Pharmacology
  15. Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease
    Dingxin Qin, George C. Leef, Mian Bilal Alam, Rohit Rattan, Muhammad Bilal Munir, Divyang Rajesh Patel, Furqan Habib Khattak, EVAN C. ADELSTEIN, Sandeep K Jain, Samir Saba · 2015 · Cardiology Journal
  16. Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
    Jonathan Paul Piccini, David F. Kong · 2011 · EP Europace
  17. Mortality and ventricular arrhythmias in patients on d,l-sotalol for rhythm control of atrial fibrillation: A nationwide cohort study
    Hanna Lenhoff, Hans Järnbert-Petersson, Börje Darpö, Per Tornvall, Mats Frick · 2023 · Heart Rhythm
  18. Personalized medicine and atrial fibrillation: will it ever happen?
    Steven A. Lubitz, Patrick T. Ellinor · 2012 · BMC Medicine
  19. Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge
    P. Stoneman, Peadar Gilligan, P. Mahon, Richard G. Sheahan · 2017 · Irish Journal of Medical Science (1971 -)
  20. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
    Naqash J Sethi, Sanam Safi, Emil Eik Nielsen, Joshua Buron Feinberg, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2017 · Systematic Reviews
  21. Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland
    Jonas A. Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le-Bagousse, Mårten Rosenquist, Peter Lindgren · 2012 · The European Journal of Health Economics
  22. Management of tachyarrhythmias in pregnancy – A review
    Priyanka Kugamoorthy, DANNA A. SPEARS · 2020 · Obstetric Medicine
  23. Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies
    Yehuda Handelsman, Thomas Jared Bunch, Helena W. Rodbard, Benjamin Adam Steinberg, Munveer Thind, Grégory Bigot, L Konigsberg, Mattias Wieloch, Peter Russell Kowey · 2022 · Journal of Diabetes and its Complications
  24. Update on the Clinical Management of Atrial Fibrillation: Guidelines and Beyond
    Anne B. Curtis · 2011 · Postgraduate Medicine
  25. Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers
    Rui Andre Providencia, Carlo de Asmundis, K. R. Julian Chun, Gian‐Battista Chierchia, Pascal Defaye, Frédéric Anselme, António Creta, Pier David Lambiase, Boris Schmidt, Shaojie Chen et al. · 2019 · Journal of Cardiovascular Electrophysiology
  26. Is amiodarone still a reasonable therapeutic option for rhythm control in atrial fibrillation?
    Sérgio Barra, João José Primo, Helena Gonçalves, Serge Bovéda, Rui Andre Providencia, Andrew A. Grace · 2022 · Revista Portuguesa de Cardiologia
  27. Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)
    Golitsyn Sp, Е. П. Панченко, Nikolay Yu. Mironov, Беляева Мария Михайловна, D. A. Gagloeva, Eugenia M. Elfimova, Кропачева Екатерина Станиславовна, Lada Iu. Laiovich, Aleksander Yu. Litvin, E. B. Maykov et al. · 2025 · Eurasian heart journal
  28. The Management of Patients with Atrial Fibrillation and Dronedarone’s Place in Therapy
    Marc C. Cohen, Catalin Boiangiu · 2011 · Advances in Therapy
  29. Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study
    James M. Brophy, Lyne Nadeau · 2022 · CJC Open
  30. Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study
    Anjana Mohan, Zahra Majd, Trang Trinh, Rutugandha Paranjpe, Susan Abughosh · 2022 · International Journal of Clinical Pharmacy
  31. Dronedarone for the treatment of non-permanent atrial fibrillation: National Institute for Health and Clinical Excellence guidance
    Alan John Camm, Irene Savelieva · 2013 · Heart
  32. Proarrhythmia and death with antiarrhythmic drugs for atrial fibrillation, and the unfulfilled promise of comparative effectiveness research
    Fabian R. Reimold, Matthew R. Reynolds · 2018 · American Heart Journal
  33. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Chinese Society of Cardiology, Chinese Medical Association, Heart Rhythm Committee of Chinese Society of Biomedical Engineering · 2024 · Cardiology Discovery
  34. Factors influencing early recurrence of atrial fibrillation among elderly patients following radiofrequency catheter ablation and the impact of different antiarrhythmic regimens
    Changdong Fei, Caitong Zhao, Yan Ma, Yupeng Liu, Renzheng Chen, Hualin Zhang · 2024 · Frontiers in Medicine
  35. Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis
    Hannah Jane Elizabeth Wilson, Declan Patton, Zena E. H. Moore, Tom O’Connor, Linda Nugent · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  36. New evidence: Cryoballoon ablation vs. antiarrhythmic drugs for first-line therapy of atrial fibrillation
    Jason G. Andrade, Gian‐Battista Chierchia, Malte Kuniss, Oussama M. Wazni · 2021 · EP Europace
  37. Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N‐desbutyldronedarone: Application to prospective simulation of complex drug–drug interaction with rivaroxaban
    Jacqueline Wen Hui Leow, Xiao Jun Ang, Eric Chun Yong Chan · 2023 · British Journal of Clinical Pharmacology
  38. Early rhythm control in atrial fibrillation anno 2024
    Broes Martens, Mattias Francis Duytschaever · 2024 · Acta cardiologica. Supplementum
  39. Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
    Stefan Hans Hohnloser · 2012 · Clinical Cardiology
  40. Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation
    Sarasa M.A. Johnson, James M. Brophy · 2016 · International Journal of Cardiology
  41. Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation
    Zengxiang Dong, Hong Yao, Zhuangzhuang Miao, Hao Wang, Rongsheng Xie, Ye Wang, Yingfang Shang, Chunlin Gong, Zhaoguang Liang · 2017 · Biomedical Reports
  42. Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study
    So‐Ryoung Lee, Eue‐Keun Choi, Ji-Hyun Kim, Jung-Ae Kim, Tae-Yeon Kwon, Young Eun Lee, Seil Oh · 2020 · Scientific Reports
  43. Cardiac Arrhythmias and Pregnancy
    DANNA A. SPEARS, Uri Elkayam · 2019 · Wiley eBooks
  44. Cryoablation as Initial Therapy for Atrial Fibrillation
    Riccardo Proietti, Riccardo Vio, Gregory Y.H. Lip · 2021 · New England Journal of Medicine
  45. Clinical Practice Guideline
    Stephan Willems, Felix Konrad Wegner, Lars Eckardt · 2025 · Deutsches Ärzteblatt international
  46. Distribution of amiodarone between lipid nanocapsules and residual micelles: Tangential flow filtration as a purification method and its impact on cytotoxicity
    Jaspe Chen, Sophie Tamareille, Etienne Chèvremont, Jean-Christophe Gimel, Brice Calvignac, David Dallerac, Nolwenn Lautram, Tanguy Le Lay, Clara Rapenne, Isabelle Verdu et al. · 2025 · International Journal of Pharmaceutics
  47. Rate Versus Rhythm Control for Atrial Fibrillation: From Affirm to EAST-AFNET 4 – a Paradigm Shift
    Sherif Roman, Kevin B. Patel, David Hana, Kenneth Cory Guice, Jay D. Patel, Christopher Stadnick, Amir Basta, Rami N. Khouzam · 2022 · Future Cardiology
  48. Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
    Wei‐Ru Chiou, Po‐Lin Lin, Chun‐Che Huang, Jen-Yu Chuang, Lawrence Yu‐Min Liu, Min‐I Su, Feng‐Ching Liao, Jen‐Yuan Kuo, Cheng‐Ting Tsai, Yih‐Jer Wu et al. · 2022 · Scientific Reports
  49. Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)
    Pavel P. Osmancik, Štěpán Havránek, Veronika Bulková, Jan Chovančík, Tomáš Roubíček, Dalibor Heřman, Z Čarná, Vladimír Tuka, Martin Matoulek, Martin Fiala et al. · 2022 · BMJ Open
  50. Drug-induced AF: Arrhythmogenic Mechanisms and Management Strategies
    Bingxun Li, Mingjie Lin, Lin Wu · 2024 · Arrhythmia & Electrophysiology Review
  51. Management of atrial fibrillation: focus on the role of dronedarone
    Judy W. M. Cheng · 2011 · Open Access Emergency Medicine
  52. Science deserves justice: The results of the CABANA trial are positive and support catheter ablation of atrial fibrillation for reducing mortality and hospitalizations
    Rui Andre Providencia, Pedro Adragão · 2019 · Revista Portuguesa de Cardiologia
  53. Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
    Mengran Zhang, Yufeng Ren, Luying Wang, Jianhao Jia, Lei Tian · 2021 · Frontiers in Public Health
  54. Atrial fibrillation: Rate control or rhythm control?
    Radhika Deshpande, Yasser Al‐Khadra, Raad Al Tamimi, Nour Albast, Mohamed Rafa Labedi · 2022 · Cleveland Clinic Journal of Medicine
  55. Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure
    Majd A. El‐Harasis, Christopher V. DeSimone, Xiaoxi Yao, Peter A. Noseworthy · 2019 · Cardiology Clinics
  56. Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation
    Yun Gi Kim, Hyoung Seok Lee, Hoseob Kim, Mina Kim, Joo Hee Jeong, Yun Young Choi, Jaemin Shim, Jong‐Il Choi, Young-Hoon Kim · 2025 · Journal of Clinical Medicine
  57. Clinical Pearls in Using Antiarrhythmic Drugs in the Outpatient Setting
    Mary H. Parker, Cynthia A. Sanoski · 2015 · Journal of Pharmacy Practice
  58. Peculiarities of therapy for heart rhythm disorders in patients with chronic heart failure
    Ekaterina Iosifovna Tarlovskaya · 2017 · Kardiologiia
  59. Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial Fibrillation
    2014 · Cardiovascular Pharmacology Open Access
  60. Strategies for Rhythm Control in Atrial Fibrillation
    Kumar Narayanan · 2020 · Indian Journal of Clinical Cardiology
  61. The safety and efficacy of sotalol in the management of acute atrial fibrillation: a retrospective case control study
    Chris Sawh, Shabnam Rashid · 2016 · Interventional Cardiology
  62. ATRIAL FIBRILLATION FOLLOWING CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES (PART 2)
    В. В. Ломиворотов, Sergey Mihailovich Efremov, Evgeny A. Pokushalov, Бобошко Владимир Александрович · 2017 · Messenger of Anesthesiology and Resuscitation
  63. Rise and fall of dronedarone: the need for new drugs
    Bernhard M. Kaess, Joachim R. Ehrlich · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
  64. Dronedarone vs Sotalol Among Patients With Atrial Fibrillation
    Jagmeet P. Singh, Mattias Wieloch, Shannon L. Reynolds, Carina Blomström‐Lundqvist, Alexander T. Sandhu, A. John Camm, Shaum Kabadi, Krishna N. Pundi, Mintu P. Turakhia, Rania Boiron et al. · 2025 · JACC. Clinical electrophysiology
  65. Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry
    Xiaoxia Hou, Liu He, Xin Du, Guohong Wang, Jianzeng Dong, Changsheng Ma · 2020 · Chinese Medical Journal
  66. Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
    Yihan Li, Tong Hu, Mingjie Lin, Qinhong Wang, Wenqiang Han, Jingquan Zhong · 2023 · Clinical Pharmacology Advances and Applications
  67. Ablation or drug therapy for initial atrial fibrillation
    Jason G. Andrade · 2024 · Annals of Cardiothoracic Surgery
  68. Analysis of randomized controlled studies comparing ablation with antiarrhythmic drugs
    Nawar Alhourani, Christian Ellermann, Julian Wolfes, Christian G. Meyer, Lars Eckardt · 2025 · Trends in Cardiovascular Medicine
  69. A Review of Structure Activity Relationship of Amiodarone and Its Derivatives
    Moiz A. Siddiqui, Amjad Khan, Mehreen Zaka · 2016 · Open Journal of Medicinal Chemistry
  70. 2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation
    Ki‐Woon Kang, Jaemin Shim, Jinhee Ahn, Dae In Lee, Jun Kim, Boyoung Joung, Kee‐Joon Choi · 2018 · Korean Journal of Medicine
  71. Atrial Fibrillation Ablation in Heart Failure Patients
    Michael Derndorfer, Shaojie Chen, Helmut Pürerfellner · 2021 · Journal of Clinical Medicine
  72. How to: Antiarrhythmika in der klinischen Anwendung
    Henrike A. K. Hillmann, Konstanze Betz, Dominik Linz, David Duncker · 2023 · Herzschrittmachertherapie + Elektrophysiologie
  73. A value-based budget impact model for dronedarone compared with other rhythm control strategies
    Jennifer Ken-Opurum, Sesha SS Srinivas, Pratyusha Vadagam, L Faith, Seojin Park, Scott L. Charland, Andrew Revel, Ronald Preblick · 2023 · Journal of Comparative Effectiveness Research
  74. The Efficacy and Tolerability of Commonly Used Agents to Prevent Recurrence of Atrial Fibrillation After Successful Cardioversion
    Hanney Gonna, Mark Michael Gallagher · 2014 · American Journal of Cardiovascular Drugs
  75. The Politics of Access to Expensive Drugs: INESSS and the Innovative Pharmaceutical Industry
    David Hughes · 2012 · Healthcare policy
  76. Cryoablation as a first-line therapy for atrial fibrillation: current status and future prospects
    Jason G. Andrade, Marc William Deyell, Marc Dubuc, Laurent Macle · 2022 · Expert Review of Medical Devices
  77. Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?
    Bharath Rajagopalan, Anne B. Curtis · 2015 · Postgraduate Medicine
  78. Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation
    Michael H Kim · 2012 · Expert Review of Clinical Pharmacology
  79. The long and short of antiarrhythmic drug treatment
    A. John Camm, Irene Savelieva · 2012 · The Lancet
  80. Comparison of the efficacy and safety of different doses of nifekalant in the instant cardioversion of persistent atrial fibrillation during radiofrequency ablation
    Zhenyu Zhai, Zirong Xia, Zhen Xia, Jinzhu Hu, Jianxin Hu, Bo Zhu, Qinmei Xiong, Yanqing Wu, Kui Hong, Qi Chen et al. · 2020 · Basic & Clinical Pharmacology & Toxicology
  81. Does Sotalol Still Have a Role in the Management of Arrhythmias?
    Sahan P. Semasinghe Bandaralage, Selvanayagam Nirthanan, Selvanayagam Niranjan · 2016 · American Journal of Therapeutics
  82. Dronedarone
    Stefan Hans Hohnloser · 2014 · Journal of the American College of Cardiology
  83. Cost-Effectiveness of Antiarrhythmic Drugs for Treating Paroxysmal or Persistent Atrial Fibrillation in China: An Economic Evaluation
    Fuming Li, Dunming Xiao, Yu Xia, Junling Weng, Shimeng Liu, Yingyao Chen · 2025 · Clinical Therapeutics
  84. Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation
    Xianglin Long, Han Lv, Jingliang Zhang, Xiaoyan Wang, Shan Tu, Xu Deng, Lixiong Zeng, Wenzhi Luo, Fei Ye, Zhihui Zhang · 2025 · Cardiovascular Therapeutics
  85. Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
    Astrid Fritz Hansson, Angelo Modica, Henrik Renlund, Christina Christersson, Claes Held, Gorav Batra · 2024 · Open Heart
  86. Safety and efficacy of amiodarone and dronedarone for early rhythm control in EAST-AFNET 4
    Laura Rottner, Marc Daniel Lemoine, Lars Eckardt, Katrin Borof, A. John Camm, Andreas Goette, GÜNTER E. BREITHARDT, Andreas Metzner, Ulrich Schotten, Antonia Zapf et al. · 2025 · Clinical Research in Cardiology
  87. Spectral Analysis of Baseline Electrocardiogram During Atrial Fibrillation Predicts Response to Antiarrhythmic Drug Therapy in Patients With Persistent Atrial Fibrillation
    Stavros Stavrakis, JOHN W. DYER, Edward Koomson, Benjamin J. Scherlag, Bhaskar Bhardwaj, Ralph Lazzara, Sunny S. Po · 2016 · Journal of Cardiovascular Electrophysiology
  88. Comparación de la eficacia y seguridad de flecainida y dronedarona como terapias antiarrítmicas para mantenimiento de ritmo sinusal en fibrilación auricular
    Ruth María Sánchez Soriano, Carlos Israel Chamorro Fernández, Juan M. Ruiz-Nodar, Antonio Javier Chamorro Fernández, Guillermo Grau Jornet, Julio Nuñez Villota · 2017 · Archivos de cardiología de México
  89. STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
    С. Г. Канорский, Yu. S. Kovalenko · 2017 · Russian Journal of Cardiology
  90. Incomplete endothelialization of WatchmanTM Device: Predictors and Implications from Two Cases
    Dhanunjaya Lakkireddy · 2019 · Journal of Atrial Fibrillation
  91. Update Vorhofflimmern: Die ESC-Leitlinien 2020 sowie aktuelle Daten zur frühen antiarrhythmischen Therapie
    Ruben Schleberger, Andreas Rillig, Paulus F. Kirchhof, Andreas Metzner, Bruno Reißmann · 2021 · Herzschrittmachertherapie + Elektrophysiologie
  92. Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1
    Seri Hanayneh, Mark Edward Panna, William M. Miles, Ramil Goel · 2021 · Current Treatment Options in Cardiovascular Medicine
  93. Meta‑analysis of the efficacy and safety of nifekalant in the conversion of atrial fibrillation
    Peng Liu, Kaiyuan Li, Shuya Wang, Miao Liu, Lei Wang, Guohai Su · 2022 · Experimental and Therapeutic Medicine
  94. Association of sotalol versus atenolol therapy with survival in dogs with severe subaortic stenosis
    Sonja S. Tjostheim, A. Showers, Catlin A. Obernberger, M. Shear · 2023 · Journal of Veterinary Cardiology
  95. Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
    Jennifer Ken-Opurum, Sesha SS Srinivas, Seojin Park, Scott L. Charland, Andrew Revel, Ronald Preblick · 2023 · Journal of Comparative Effectiveness Research
  96. Re-gaining confidence in contemporary dronedarone use
    Joachim R. Ehrlich · 2018 · International Journal of Cardiology
  97. Antiarrhythmic Drugs for Atrial Fibrillation in the Real World
    Gerald V. Naccarelli · 2019 · JACC. Clinical electrophysiology
  98. Advances in the management of atrial fibrillation
    Anthony C. Li, Elijah Raphael Behr · 2012 · Clinical Medicine
  99. Diretriz Brasileira de Fibrilação Atrial – 2025
    F. D. Cintra, C. Pisani, André Gustavo da Silva Rezende, Benhur Davi Henz, L. Armaganijan, Maurício Pimentel, R. D. Lopes, T. A. Do Nascimento, A. Lorga, Afonso Luiz Tavares de Albuquerque et al. · 2025 · Arquivos Brasileiros de Cardiologia
  100. Clinical and Economic Outcomes of Dronedarone Versus Amiodarone Among Patients With Atrial Fibrillation
    Benjamin Adam Steinberg, Firas M. Dabbous, Ron Preblick, Divya Shridharmurthy, David S. McKindley, Jason Rashkin, Samuel Huse, Chris Colby, Jagmeet P. Singh · 2025 · Journal of the American Heart Association